Opiant Pharmaceuticals Inc. (OPNT): The selloff from $21 to $16 is quite lar...

Followed By	2
Posts	126
Boards Moderated	0
Alias Born	09/20/2017

Leonard McKinley

Thursday, November 14, 2019 12:30:35 AM

Re: catty post# 1486

The selloff from $21 to $16 is quite large. Why do you think this happened? This looks very interesting to me. I do not understand the skeptics out there. Perhaps someone can enlighten me.

Recent OPNT News

Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 05/17/2022 08:05:15 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 05/16/2022 08:13:25 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 05/16/2022 08:11:32 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 05/10/2022 08:10:23 PM
Opiant Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/10/2022 08:01:00 PM
Opiant Pharmaceuticals to Report First Quarter 2022 Financial Results and Host Conference Call and Webcast on May 10, 2022 • GlobeNewswire Inc. • 05/03/2022 12:00:00 PM
Opiant Pharmaceuticals Issues Statement in Response to Fake Press Release • PR Newswire (US) • 04/29/2022 04:49:00 PM
Opiant Pharmaceuticals Issues Statement in Response to Fake Press Release • PR Newswire (US) • 04/29/2022 04:47:00 PM
Opiant Pharmaceuticals Announces Positive Topline Results from Head-to-Head Pharmacodynamic Study Comparing OPNT003, Nasal Nalmefene, to Nasal Naloxone • GlobeNewswire Inc. • 04/27/2022 08:01:00 PM
Proxy Statement (definitive) (def 14a) • Edgar (US Regulatory) • 04/18/2022 08:07:45 PM
Securities Registration: Employee Benefit Plan (s-8) • Edgar (US Regulatory) • 03/17/2022 08:02:22 PM
Annual Report (10-k) • Edgar (US Regulatory) • 03/15/2022 08:10:19 PM
Opiant Pharmaceuticals GAAP EPS of $0.11 beats by $0.01, revenue of $13.8M beats by $0.54M • Seeking Alpha • 03/15/2022 08:09:33 PM
Opiant Pharmaceuticals Announces Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/15/2022 08:05:00 PM
Opiant Pharmaceuticals Q4 Earnings Preview • Seeking Alpha • 03/14/2022 09:35:56 PM
Opiant Pharmaceuticals to Participate in 32nd Oppenheimer Healthcare Conference • GlobeNewswire Inc. • 03/10/2022 09:01:00 PM
Opiant Pharmaceuticals to Report Fourth Quarter 2021 Financial Results and Host Conference Call and Webcast on March 15, 2022 • GlobeNewswire Inc. • 03/07/2022 09:05:00 PM
Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/11/2022 02:33:19 PM
Opiant Pharmaceuticals Announces Positive Pharmacokinetic, Safety, and Tolerability Results From a Multi-Dose Study for OPNT003, Nasal Nalmefene • GlobeNewswire Inc. • 02/10/2022 01:00:00 PM
Opiant Pharmaceutical briefly spikes on takeover speculation • Seeking Alpha • 02/08/2022 05:58:48 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/27/2022 09:04:46 PM
Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 01/27/2022 03:17:38 PM
Opiant to get additional $2.2M from BARDA for OPNT003 to treat opioid overdose • Seeking Alpha • 01/24/2022 09:35:38 PM
Opiant Pharmaceuticals Announces Additional $2.2 million Funding Under BARDA Contract for OPNT003 Nasal Nalmefene Development Program • GlobeNewswire Inc. • 01/24/2022 09:05:00 PM
Opiant Pharmaceuticals Announces First Patient Dosed in Phase 2 Trial of OPNT002, Nasal Naltrexone, for Alcohol Use Disorder • GlobeNewswire Inc. • 01/20/2022 10:48:28 PM

More OPNT News

InvestorsHub NewsWire

FEATURED American Green, Inc. ™ (OTC:ERBB) Officially Acquires Vendweb - Supplier of its AGX Facial Recognition and Over- 21 Age Smart Vending Machine • May 17, 2022 7:30 AM

B2 Digital's B2FS 161 Full Production iPhone 13 Pro Max Movie to be Released Free to Viewers on YouTube Tonight at 7 p.m. ET • BTDG • May 17, 2022 12:30 PM

Kona Gold Beverage, Inc's Ooh La Lemin Lemonades to be Sold in Winn-Dixie Stores • KGKG • May 17, 2022 9:00 AM

HealthLynked Announces Acquisition of Aesthetic Enhancements, LLC, and Reports First Quarter 2022 Results Including a Significant Reduction in Net Loss • HLYK • May 17, 2022 8:00 AM

Progressive Care Reports First Quarter 2022 Financial Results Highlighted by 5% Growth in Revenue to $10.1 Million • RXMD • May 17, 2022 7:28 AM

OTC: ILUS, ILUS International (Ilustrato Pictures International Inc) Summarizes Its First Quarter of 2022 Disclosure • ILUS • May 16, 2022 4:00 PM

HNRC ENGAGES INTERCAPITAL ENERGY • HNRC • May 16, 2022 9:47 AM

Integrated Ventures Reports Q3/2022 Financial Results With Total Revenues Of $1,431,819 And Gross Profit Of $307,492.00. • INTV • May 16, 2022 9:00 AM

Splash Beverage Group Reports Record First Quarter 2022 Financial Results. Revenues Increase 86% Year over Year with $4 Million in Gross Sales as Company Signs 12 New or Expanded Distribution Agreements • SBEV • May 16, 2022 8:02 AM

RENAVOTIO, INC. (RIII) Provides Shareholder updates • RIII • May 13, 2022 3:38 PM

Demand Brands and Truleaf discussing the future of DB's retail footprint • DMAN • May 13, 2022 3:11 PM

OMID Posts First-Quarter 2022 Financial Statements • OMID • May 13, 2022 10:00 AM

"VAPR" E-Cite Motors Profiled as AMAZING EV Auto Investment in EV Auto Insider - Above GOOD Tesla, and Those Making its' TERRIBLE Investment List • VAPR • May 13, 2022 9:49 AM

American Green, Inc. ™ (OTC:ERBB) Board Votes to Exercise its Option to Buy 40,000 square foot "Cypress Chill" Cannabis Building for $3,750,000 • ERBB • May 13, 2022 8:30 AM

Progressive Care to Report First Quarter Financial Results on May 17, 2022 • RXMD • May 13, 2022 8:06 AM

Start posting your company's news
Only $200 per official company press release!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Quotes:

IHub:

More OPNT News

Detailed Quote